References
- Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santaro A, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004; 351: 337–45
- Wong S-F. Cetuximab: An epidermal growth factor receptor monoclonal antibody for the treatment of colorecal cancer. Clin Ther 2005; 27: 684–94